CD68 and astrocytoma (excluding glioblastoma): This is in line with a study by Klein el al.41, who reported on a immunohistochemical double-labeling study with Ki-67 as proliferation-marker and Ki-M1P (CD68) as microglia marker in 40 astrocytomas WHO grade I-IV.